Avatec® / Baciferm®

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 141109
  • Animal drug product ID 1521

What the source publishes

Holder
Phibro Animal Health Corp.
Active ingredients
Bacitracin Zinc Lasalocid
Form
Medicated Feed
Routes
Oral
Supply regime
OTC

Names this record is found by

Complete source data
us:fda:animaldrugs:1161:1521
{
  "form": "Medicated Feed",
  "name": "Avatec® / Baciferm®",
  "holder": "Phibro Animal Health Corp.",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "OTC",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Turkeys:1660": "Growing turkeys"
    },
    "sortOrder": 0,
    "withdrawals": [
      "Turkey: zero days before slaughter."
    ],
    "doseFormName": "Medicated Feed",
    "applicationId": null,
    "specifications": "Lasalocid is supplied as a Type A medicated article containing 90.7 grams lasalocid activity per pound. \r\nBacitracin zinc is supplied as a Type A medicated article in a concentrations of 50 grams bacitracin activity per pound.",
    "proprietaryName": "Avatec® / Baciferm®",
    "proprietaryNameId": 1521,
    "statusDescription": "OTC"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2024-11-12",
    "sponsorName": "Phibro Animal Health Corp.",
    "applicationId": 1161,
    "applicationType": "N",
    "proprietaryName": "Avatec® / Baciferm®\n",
    "applicationNumber": 141109,
    "activeIngredientName": "Bacitracin Zinc\nLasalocid\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "1660",
      "label": "Turkeys",
      "native": {
        "key": "Turkeys:1660",
        "population": "Growing turkeys"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Growing turkeys",
      "canonicalId": "turkey",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2024-11-12",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [
    {
      "native": "Turkey: zero days before slaughter.",
      "status": "unparsed"
    }
  ],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 1161,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Bacitracin Zinc\nLasalocid\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Lasalocid",
      "activeIngredientTolerance": "Tolerances for lasolocid residues are established as follows: \r\n\r\n      1.  Cattle:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 0.7 part per million \r\n      2.  Chickens:  (I) Skin with adhering fat (the target tissue). The tolerance for parent lasalocid (the marker residue) is 1.2 parts per million.\r\n(ii) Liver. The tolerance for parent lasalocid (the marker residue) is 0.4 part per million. \r\n      3. Turkeys:   (I) Skin with adhering fat (the target tissue). The tolerance for parent lasalocid (the marker residue) is .4 part per million.\r\n(ii) Liver. The tolerance for parent lasalocid (the marker residue) is 0.4 part per million. \r\n       4.  Rabbits:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 0.7 part per million.\r\n       5.  Sheep:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 1.0 part per million"
    },
    {
      "activeIngredientName": "Bacitracin Zinc",
      "activeIngredientTolerance": "The tolerance for residues of bacitracin from zinc bacitracin or bacitracin methylene disalicylate in uncooked edible tissues of cattle, swine, chickens, turkeys, pheasants, and quail, and in milk and eggs is 0.5 part per million\r\n\t\t\t\t\t\t\t\t\t\t\t"
    }
  ],
  "nativeApplicationNumber": 141109,
  "nativeProprietaryNameId": 1521,
  "restrictionObservations": [
    {
      "indicationText": "For the prevention of coccidiosis caused by <i>Eimeria meleagrimitis</i>, <i>E. gallopavonis</i>, and\r\n<i>E. adenoeides</i>, and for increased rate of weight gain and improved feed efficiency in growing\r\nturkeys.",
      "limitationText": "Feed continuously as sole ration.",
      "populationText": "Growing Turkeys"
    }
  ],
  "withdrawalPeriodsStatus": "reported-unparsed",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:1161:1521"